Logo

CHNR

China Natural Resources, Inc.

CHNR

China Natural Resources, Inc. • NASDAQ
$3.65 ▲ 1.67% (+0.06)
Market Cap $4.50 M
52w High $8.20
52w Low $3.16
Dividend Yield 0%
P/E -9.86
Volume 4.00K
Outstanding Shares 1.23M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2024 $0 $-1.991M ▼ $57.84K ▲ 0% $-0.324 ▼ $1.99M ▲
Q2-2024 $0 $1.998M ▼ $-61K ▲ 0% $-0.006 ▲ $-1.997M ▲
Q4-2023 $0 $8.004M ▲ $-3.099M ▲ 0% $-3.71 ▲ $-7.447M ▼
Q2-2023 $0 ▼ $4.879M ▼ $-10.742M ▲ 0% ▲ $-4.4 ▼ $-4.876M ▲
Q4-2022 $2.117M $11.418M $-13.286M -627.586% $-1.62 $-11.784M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2024 $3.082M ▼ $260.889M ▲ $172.827M ▼ $88.062M ▲
Q2-2024 $4.756M $253.807M $177.812M $75.995M
Q4-2023 $4.756M ▼ $253.807M ▼ $177.812M ▼ $75.995M ▲
Q2-2023 $33.209M ▲ $568.853M ▲ $401.247M ▲ $56.645M ▼
Q4-2022 $32.695M $319.991M $142.542M $67.769M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2024 $-3.16M ▼ $-7.405M ▼ $1K ▲ $15.095M ▲ $-1.671M ▼ $-7.409M ▼
Q2-2024 $-122 ▲ $-11.846K ▼ $0 ▼ $15.836K ▲ $0 ▲ $-11.85K ▼
Q4-2023 $-526.59K ▲ $1.447M ▲ $2.439K ▲ $-5.128M ▼ $-26.942M ▼ $1.447M ▲
Q2-2023 $-650.116K ▲ $168.66K ▲ $-151.203K ▼ $39.82K ▲ $32.209K ▲ $167.8K ▲
Q4-2022 $-13.286M $-4.152M $3.526M $-9.466M $-60.525M $-4.157M

Five-Year Company Overview

Income Statement

Income Statement The company is operating at a very small scale, with almost no revenue in recent years. Results have swung between modest losses and modest profits, but the recent pattern is one of low activity and small operating losses rather than a growing operating business. Losses appear to have narrowed lately, yet this is happening against a backdrop of minimal sales, which suggests cost control and restructuring rather than true revenue-driven improvement. Reported earnings per share have moved sharply largely because of share structure changes, not because the underlying business suddenly became much stronger or weaker.

Balance Sheet

Balance Sheet The balance sheet is small and fairly light. Total assets and shareholders’ equity have both drifted down over the last several years, which points to gradual erosion of the company’s capital base. Debt is present but not overwhelming relative to the size of the company; however, cash balances are very thin, leaving little cushion for setbacks. Overall, the financial position looks fragile: not heavily leveraged, but also not strongly capitalized or very liquid, so the company likely depends on external funding or successful deals to support its plans.

Cash Flow

Cash Flow Cash generation from the core business has been slightly negative in most years, with operating cash flow just below break-even. Free cash flow mirrors this pattern, indicating the business is not currently self-funding. On the positive side, there has been little to no spending on long-term assets, which keeps cash needs lower. On the negative side, this also means limited reinvestment into building a stronger operating base. In practical terms, the company’s cash flow profile looks weak and reliant on occasional financings rather than steady cash coming in from operations.

Competitive Edge

Competitive Edge Despite being categorized in waste management, the company’s real story is a legacy in mining and a move toward a diversified holding structure, including healthcare and critical minerals. It is a very small player without a clear dominant product or brand, so its competitive position does not rest on scale or market share. Instead, its edge, if any, comes from its experience in acquisitions, its public listing that can be used to raise capital, and longstanding relationships with government and technical bodies in China. These strengths are offset by its small size, inconsistent operating history, and dependence on finding and integrating attractive deals in markets where competition for good assets is intense.

Innovation and R&D

Innovation and R&D Innovation here is strategic rather than technological. The company is reinventing itself from a traditional resource explorer into a diversified investment platform focused on areas like healthcare and lithium, which are seen as structural growth themes. The planned acquisition of a lithium mining asset and the stated focus on China’s healthcare demand are examples of this pivot. There is no clear evidence of heavy in-house research and development; instead, the company aims to acquire businesses that already possess valuable technology, licenses, or know-how. This model can be flexible and fast-moving, but it also concentrates risk in management’s ability to choose and integrate the right targets.

Summary

Overall, China Natural Resources looks more like a restructuring and deal-driven story than a mature operating business. Its recent financials show minimal revenue, small but persistent operating losses, a shrinking asset base, and limited cash, all of which underline the early and fragile nature of its transition. The potential upside lies in successful execution of its acquisition and diversification strategy, especially in lithium and healthcare, where industry trends are favorable. The main risks are execution missteps, ongoing reliance on external funding, and the absence of a proven, cash-generating core business today. Any view of the company’s prospects hinges less on current financial strength and more on confidence in its ability to complete and integrate future deals and manage its transformation effectively.